Galderma Group AG - Registered Shares

NEW
OTCPK:GDERF (Switzerland)   Registered Shares
$ 215.45 +4.7 (+2.23%) 12:52 PM EST
83.51
P/B:
6.58
Market Cap:
$ 52.72B
Enterprise V:
$ 54.69B
Volume:
1.00
Avg Vol (2M):
735.00
Trade In:
Volume:
1.00
Avg Vol (2M):
735.00

Business Description

Description
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs more than 7,500 people.
Name Current Vs Industry Vs History
Cash-To-Debt
0.28
Equity-to-Asset
0.61
Debt-to-Equity
0.34
Debt-to-EBITDA
2.4
Interest Coverage
5
Piotroski F-Score
7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
7.29
Distress
Grey
Safe
Beneish M-Score
-2.66
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
43.12
9-Day RSI
47.72
14-Day RSI
49.36
3-1 Month Momentum %
16
6-1 Month Momentum %
2.73
12-1 Month Momentum %
47.28

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
1.19
Quick Ratio
0.93
Cash Ratio
0.38
Days Inventory
109.9
Days Sales Outstanding
60.04
Days Payable
163.68

GF Valueâ„¢

Galderma Group AG Filings

Filing Date Document Date Form
No Filing Data

Galderma Group AG Stock Events

Financials Calendars
Event Date Price ($)
Second quarter earnings conference call for 2026 2026-07-24 In 25 days
Second quarter earnings results for 2026 2026-07-24 In 25 days
CHF 0.350000 Cash Dividend 2026-04-24 207.10 (+0.36%)
General meeting for 2026 2026-04-22 15:00 175.61 (-7.60%)
Annual report for 2025 2026-03-05 195.72 (-0.07%)
Fourth quarter earnings results for 2025 2026-03-05 195.72 (-0.07%)
Second quarter earnings conference call for 2025 2025-07-24 152.00 (+0.00%)
Second quarter earnings results for 2025 2025-07-24 152.00 (+0.00%)
CHF 0.150000 Cash Dividend 2025-04-25 108.10 (+0.00%)
General meeting for 2025 2025-04-23 108.10 (+0.00%)
Show
Entries

Guru Commentaries on OTCPK:GDERF

No articles.

Articles on Galderma Group AG

No articles.

Headlines

See More
  • 1
No news.
  • 1